Christopher Braunack > Kirkland & Ellis International LLP > London, England > Lawyer Profile
Kirkland & Ellis International LLP Offices
30 ST MARY AXE
LONDON
EC3A 8AF
England
- Firm Profile
- Go to...
Christopher Braunack
Work Department
Investment funds
Position
Christopher Braunack is an investment funds partner in the London office of Kirkland & Ellis International LLP. Christopher primarily advises private investment fund sponsors in relation to the structuring and establishment of private investment funds investing across all major alternative investment strategies in addition to the carried interest and co-investment plans associated with such funds. He also advises on a broad range of other transactions relating to private investment funds including secondary transactions, fund restructurings, co-investment arrangements, continuation vehicles, management team spin-outs and management company transactions.
Career
2010 to present Kirkland & Ellis International LLP; 2006-2010 Clifford Chance; 2002-2006 Corrs Chambers Westgarth
Education
University of Queensland, Australia (Bachelor of Commerce, 2003; Bachelor of Laws, 2003 Honours); Griffith University (Graduate Diploma in Legal Practice, 2004)
Top Tier Firm Rankings
- Finance > Acquisition finance
- Finance > Corporate restructuring & insolvency
- Finance > High yield
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Investment fund formation and management > Private funds
- Investment fund formation and management > Real estate funds
Firm Rankings
- Corporate and commercial > Corporate tax
- Investment fund formation and management > Fund finance
- Real estate > Property finance
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: non-contentious/regulatory
- Dispute resolution > International arbitration
- Industry focus > Life sciences and healthcare
- Corporate and commercial > Financial services: contentious
- Dispute resolution > Commercial litigation: premium